People

Peter P. Pramstaller

Peter P. Pramstaller

Peter P. Pramstaller

Head of Institute
Institute for Biomedicine

T 105 550 1740 93+

About

Peter P. Pramstaller is the founding director and head of the Institute for Biomedicine. As clinical neurologist, biomedical researcher and manager, he had the opportunity and privilege over the last 20 years to oversee and coordinate large, multilevel cross-disciplinary research projects, and to network with the international clinical-scientific community and industry.


Peter studied Medicine at the University of Innsbruck and pursued his postgraduate training and specialization in Neurology at the University of Verona, Heidelberg and the National Hospital of Neurology and Neurosurgery, Queen Square, London. In 2003 he joined the medical faculty at the University of Luebeck (Germany), where he is currently Associate Professor.


Peter's primary research focus is the molecular genetics of movement disorders, with a special focus on common age-related neurodegenerative disorders such as Parkinson's disease (PD). After his return from the National Hospital of Neurology and Neurosurgery, Queen Square (1993-1995) he started a large scale neuroepidemiology project on PD and related disorders (NEPT-Study) in South Tyrol (Northern Italy), applying a combination of epidemiology and pedigree-based genetics. Strengthened by the success of these familial studies, in 2002 he started the “GenNova Health Care Program,” an extensive, two-stage survey aimed at characterizing the genetic epidemiology of Mendelian and complex diseases in South Tyrolean population isolates (MICROS-Study). In 2004 GenNova became the Institute of Genetic Medicine, focusing its studies on genetic-epidemiological analyses among the South Tyrolean population isolates. In 2009 the institute grew into today’s Institute for Biomedicine, which in 2011 launched the CHRIS-Study (Cooperative Health Research In South Tyrol), a large prospective population cohort study, focused on understanding how the interaction between factors such as genomic, metabolomic and environmental variation contributes to human health and disease.


Peter strongly believes in transdisciplinarity, convergence and synergy. Thus, beside his biomedical research and clinical-translational focus, he has a strong interest in the development and application of novel leadership and management models in science and healthcare.


LinkedIn profile ​​​​​​​

Google Scholar profile

PubMed profile


Publications:

Rettet die Medizin: Wie Ärzte das Ruder wieder selbst in die Hand nehmen können. Mit einem Geleitwort von Fredmund Malik

Rescue the Doctor: What Doctors Urgently Need to Know About the New World of Health Care

Doctors need lessons in management


Projects

1 - 3
Project

PACE

Partnership to Accelerate Covid-19 rEsearch in South Tyrol

Duration: January 2021 - June 2022Funding:
Provincial P.-L.P. 14. Research projects (Province BZ funding /Project)

MAGAZINE Science Stories that Inspire

article

"Shifting focus from disease to human health"

Synergy between Eurac Research and Human Technopole of Milan gives new life to health research in Italy

Eurac Research logo

Eurac Research is a private research center based in Bolzano (South Tyrol) with researchers from a wide variety of scientific fields who come from all over the globe. Together, through scientific knowledge and research, they share the goal of shaping the future.

What we do

Our research addresses the greatest challenges facing us in the future: people need health, energy, well-functioning political and social systems and an intact environment. These are complex questions, and we are seeking the answers in the interaction between many different disciplines. In so doing, our research work embraces three major themes: regions fit for living in, diversity as a life-enhancing feature, a healthy society.

Great Place To Work
ISO 9001 / 2015ISO 9001:2015
05771/0
ISO 27001ISO 27001:2013
00026/0
ORCID Member

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International license.

In order to give you a better service this site uses cookies. Additionally third party cookies are used. By continuing to browse the site you are agreeing to our use of cookies.

Privacy Policy